Phase 2 Readout~quarter

Phase 2 Readout: neo100

Drug
neo100
Indication
IDH-1 mutant Recurrent High‑Grade Glioma

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: neo100 — NTHI Phase 2 Readout | BioSniper